NYSE, BEC - Beckman Coulter Inc.
Beckman Coulter, Inc. manufactures and markets products that simplify, automate
and innovate complex biomedical tests. Spanning the biomedical testing continuum
? from pioneering medical research and clinical trials to laboratory diagnostics
and point-of-care testing ? our installed base of over 200,000 systems provides
essential biomedical information to enhance health care around the world. We are
dedicated to improving patient health and reducing the cost of care.
We participate in the biomedical testing market that we estimate was about $50
billion in 2007, based on worldwide sales. Our revenue is about evenly
distributed inside and outside of the United States. Sales to clinical
laboratories represent nearly 83% of our total revenue, with the balance coming
from the life sciences markets. About 78% of our total revenue is generated by
recurring revenue consisting of supplies, test kits, services and operating-type
lease payments. ...
Read SEC Filing on NASDAQ.com »